当前位置:药药网 / 数据中心 / 生物制药海外临床研究状况
Leukemia-Specific Immune Cells (BAFFR- CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
标题(英文)
Leukemia-Specific Immune Cells (BAFFR- CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
条件
Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
干预
Biological: BAFFR-CAR T cells